FIGS, Inc. (NYSE:FIGS) Position Raised by Rhumbline Advisers

Rhumbline Advisers raised its position in shares of FIGS, Inc. (NYSE:FIGS) by 17.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 207,382 shares of the company’s stock after purchasing an additional 30,077 shares during the quarter. Rhumbline Advisers’ holdings in FIGS were worth $1,105,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Wellington Management Group LLP boosted its stake in FIGS by 321.5% during the fourth quarter. Wellington Management Group LLP now owns 3,075,794 shares of the company’s stock valued at $21,377,000 after buying an additional 2,345,994 shares in the last quarter. Eagle Asset Management Inc. acquired a new position in shares of FIGS in the 4th quarter worth approximately $12,152,000. Bamco Inc. NY grew its stake in shares of FIGS by 2.0% in the 1st quarter. Bamco Inc. NY now owns 25,731,980 shares of the company’s stock worth $128,145,000 after purchasing an additional 516,496 shares during the last quarter. Applied Fundamental Research LLC raised its holdings in shares of FIGS by 25.8% in the 1st quarter. Applied Fundamental Research LLC now owns 2,495,381 shares of the company’s stock worth $13,786,000 after purchasing an additional 511,794 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in FIGS by 16.2% during the second quarter. Bank of New York Mellon Corp now owns 2,307,304 shares of the company’s stock valued at $12,298,000 after purchasing an additional 322,358 shares during the last quarter. 92.21% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on FIGS. The Goldman Sachs Group upped their price target on FIGS from $4.25 to $4.75 and gave the company a “sell” rating in a report on Friday, August 9th. Telsey Advisory Group reaffirmed a “market perform” rating and set a $6.00 target price on shares of FIGS in a research report on Monday, August 5th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $5.40.

FIGS Stock Performance

FIGS stock opened at $5.65 on Monday. FIGS, Inc. has a 52 week low of $4.30 and a 52 week high of $7.98. The firm has a market capitalization of $961.79 million, a price-to-earnings ratio of 51.36, a P/E/G ratio of 71.07 and a beta of 1.42. The company has a 50 day moving average price of $5.81 and a 200 day moving average price of $5.38.

FIGS (NYSE:FIGS) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.01 earnings per share for the quarter. The business had revenue of $144.23 million for the quarter, compared to the consensus estimate of $142.25 million. FIGS had a return on equity of 4.94% and a net margin of 3.39%. FIGS’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.02 earnings per share. Equities analysts forecast that FIGS, Inc. will post 0.03 earnings per share for the current fiscal year.

Insider Buying and Selling at FIGS

In related news, insider Heather L. Hasson sold 40,149 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $5.70, for a total transaction of $228,849.30. Following the completion of the sale, the insider now directly owns 425,710 shares in the company, valued at $2,426,547. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have sold a total of 44,591 shares of company stock valued at $255,460 in the last 90 days. 22.30% of the stock is currently owned by corporate insiders.

FIGS Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.